These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 311940)

  • 61. A study of non-articular rheumatic disorders and their response to treatment with naproxen sodium.
    Wheatley D
    Curr Med Res Opin; 1979; 6(3):229-35. PubMed ID: 316374
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A compliance study in general practice of patients switched from phenylbutazone and oxyphenbutazone to naproxen and other non-steroidal anti-inflammatory drugs.
    Dickson DJ; English JR
    Curr Med Res Opin; 1982; 8(1):61-6. PubMed ID: 6980773
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Factors responsible for interindividual differences in the dose requirement of phenprocoumon.
    Trenk D; Althen H; Jähnchen E; Meinertz T; Oie S
    Eur J Clin Pharmacol; 1987; 33(1):49-54. PubMed ID: 3691595
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Secondary prevention of myocardial infarction: a comparison of acetylsalicylic acid, placebo and phenprocoumon.
    Breddin K; Loew D; Lechner K; Uberla K; Walter E
    Haemostasis; 1980; 9(6):325-44. PubMed ID: 7005035
    [No Abstract]   [Full Text] [Related]  

  • 65. Absence of interaction between ofloxacin and phenprocoumon.
    Verho M; Malerczyk V; Rosenkranz B; Grötsch H
    Curr Med Res Opin; 1987; 10(7):474-9. PubMed ID: 3476252
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Phenprocoumon poisonings.
    Riesselmann B; Hollmann T; Tsokos M
    Leg Med (Tokyo); 2009 Apr; 11 Suppl 1():S503-5. PubMed ID: 19409836
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Cutaneous coumarin necrosis of the breast].
    Luderschmidt C; Gutschow K; Baumeister RG; Albrich W; Eiermann W
    Dtsch Med Wochenschr; 1983 Sep; 108(37):1399-402. PubMed ID: 6884225
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficacy and tolerance of naproxen instant suspension formulation: a post-marketing survey.
    Cordaro CI; Sartini A; Celotti F
    J Int Med Res; 1988; 16(2):157-65. PubMed ID: 3288524
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of induction and inhibition of drug metabolism on pharmacokinetics and anticoagulant activity of the enantiomers of phenprocoumon in rats.
    Schmidt W; Trenk D; Jähnchen E
    Pharmacology; 1980; 21(5):313-22. PubMed ID: 7433511
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of oral anticoagulant (marcumar) on prothrombin and related components in blood coagulation.
    JOHNSON SA; CALDWELL MJ; PRIEST EM
    Circ Res; 1957 May; 5(3):252-6. PubMed ID: 13427137
    [No Abstract]   [Full Text] [Related]  

  • 71. [The influence of diazepam (valium) on the effect of phenprocoumon (marcumar) (author's transl)].
    Schunter C; Held H; Schmülling R
    Klin Wochenschr; 1978 Mar; 56(6):305-7. PubMed ID: 642402
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Effect of nerobol on indices of the coagulogram in patients with rheumatism and circulatory insufficiency of the 2B-3 stage].
    Furtel' VA
    Vrach Delo; 1977 Jun; (6):38-9. PubMed ID: 302065
    [No Abstract]   [Full Text] [Related]  

  • 73. The influence of age on the response to anticoagulants.
    Husted S; Andreasen F
    Br J Clin Pharmacol; 1977 Oct; 4(5):559-65. PubMed ID: 911605
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Individual variation in the response to phenprocoumon.
    Husted S; Andreasen F
    Eur J Clin Pharmacol; 1977; 11(5):351-8. PubMed ID: 880974
    [No Abstract]   [Full Text] [Related]  

  • 75. Sex-related differences in disposition and response to phenprocoumon in rats.
    Trenk D; Jähnchen E; Oie S
    J Pharm Pharmacol; 1988 Jun; 40(6):403-7. PubMed ID: 2901471
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Neoplastic fever responds to the treatment of an adequate dose of naproxen.
    Chang JC; Gross HM
    J Clin Oncol; 1985 Apr; 3(4):552-8. PubMed ID: 3981226
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of serum protein binding on pharmacokinetics and anticoagulant activity of phenprocoumon in rats.
    Trenk D; Jähnchen E
    J Pharmacokinet Biopharm; 1980 Apr; 8(2):177-91. PubMed ID: 7431221
    [No Abstract]   [Full Text] [Related]  

  • 78. The binding of furosemide to serum proteins in elderly patients: displacing effect of phenprocoumon.
    Andreasen F; Husted S
    Acta Pharmacol Toxicol (Copenh); 1980 Sep; 47(3):202-7. PubMed ID: 7446136
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Steady state pharmacokinetics of naproxen in elderly rheumatics compared with young volunteers.
    Gøtzsche PC; Andreasen F; Egsmose C; Lund B
    Scand J Rheumatol; 1988; 17(1):11-6. PubMed ID: 3259332
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Report of the 6th annual meeting of the European League Against Rheumatism, Athens, May 17, 1990. Naproxen--standard in rheumatism therapy. Confirmation of a tried and tested non-steroidal anti-rheumatic drug (NSAR)].
    Fortschr Med Suppl; 1990; 96():1-15. PubMed ID: 2227756
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.